Target intelligence / Profile preview

Collagen type XXVII alpha 1 chain (COL27A1)

Target
COL27A1
Molecular classification
Other, fibrillar collagen, extracellular matrix structural protein
01

Overview

Collagen type XXVII alpha 1 chain (COL27A1) is a member of the fibrillar collagen family and functions as a structural protein in the extracellular matrix of cartilage and developing bone[1][2][3][4]. It plays a crucial role during chondrogenesis and endochondral ossification, particularly in the calcification of cartilage and the transition of cartilage to bone[1][2][4]. The protein, produced as a preproprotein, includes a signal peptide, N-terminal and C-terminal propeptides, and a major triple-helical domain characteristic of fibrillar collagens[4]. Type XXVII collagen contributes to the proper organization of chondrocytes and extracellular matrix assembly, forming part of the structural framework into which bone later forms during skeletogenesis[1][2]. Mutations or disruptions in COL27A1 function can cause disorganization in the growth plate and are most notably associated with Steel syndrome, a congenital skeletal disorder[2][4]. There is currently no evidence that COL27A1 serves as a direct therapeutic target, nor are there known pharmacological modulators or biomarker applications in clinical use.

Other names
Collagen alpha-1(XXVII) chainKIAA1870MGC11337FLJ11895STLScollagen type XXVII alpha 1COL27A1
02

Biological functions

Extracellular matrix assemblyskeletal system developmentchondrocyte organizationendochondral ossificationcalcification of cartilage
03

Disease associations

OtherSteel syndromefibrochondrogenesis 1skeletal dysplasias
04

Safety considerations

Mutations in COL27A1 cause autosomal recessive Steel syndrome characterized by multiple skeletal abnormalities (short stature, hip dysplasia, scoliosis, carpal coalition)[2][4].

Beyond the preview

Go deeper on Collagen type XXVII alpha 1 chain (COL27A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen type XXVII alpha 1 chain (COL27A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call